COVID-19

Trade to Black Podcast: Zappy Zapolin On The Future Psychedelics Industry

May 5, 2022

Details Of Revive Therapeutics’ Update On Bucillamine Phase 3 Trial For COVID Treatment

Apr 26, 2022

Revive Therapeutics May Seek FDA Approval To Amend Phase 3 Endpoints In Bucillamine Trial To A Symptoms Focus

Apr 11, 2022

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Mar 29, 2022

The Movement To Relax Marijuana Laws Encounters A Headwind

Feb 22, 2022

Revive Therapeutics Updates Bucillamine Clinical Trial to Treat Coronavirus

Feb 14, 2022

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Feb 14, 2022

Comparing Psychedelics & Cannabis Stocks: Why Investors Are Asking The Wrong Questions

Feb 11, 2022

Sports Betting Stock Prices Struggle Ahead Of Super Bowl

Feb 8, 2022

PharmaDrug CEO Predicts Active Q1 For Psychedelic Investors

Jan 24, 2022